Cytosorbents (CTSO) Misses Q1 EPS by 1c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.9 million versus the consensus estimate of $9.23 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Lockheed Martin stock jumps on earnings beat, raised guidance
• Builders FirstSource (BLDR) PT Lowered to $70 at Stifel on Delayed Business Recovery
• Knight Transportation (KNX) PT Raised to $88 at Stifel on EPS Beat